top of page
Newsroom
Check on Inno4Vac latest news
New article on Vaccine Insights: “Leveraging in silico tools to accelerate vaccine manufacturing: the promise of computational fluid dynamics and hybrid process models”
A new article by Inno4vac partners in Vaccine Insights highlights how cutting-edge digital tools are transforming vaccine development and...
Jul 2
Face-to-face VAXPRED meeting summary – May 21–22, Copenhagen
On May 21–22, 2025, the VAXPRED team—Subtopic 1 of the Inno4Vac project—gathered in Lyngby, just outside Copenhagen, for a dynamic and...
Jul 1
Inno4Vac Regulatory Workshop: ‘Utilising in silico models to expedite vaccine development, testing, and lifecycle management”
Inno4Vac held a workshop in Brussels with regulators and experts from leading industry, academic, and non-governmental organisations to discuss the integration of modelling and virtual platforms to improve the vaccine production process.
Jun 4
New paper examines regulatory perspectives on in silico tools for vaccine biomanufacturing
The paper presents key outcomes from a stakeholder workshop that convened experts from academia, industry, and regulatory authorities across the EU, Canada, and the US.
May 8
New scientific article from Inno4Vac workshop on ‘design of Controlled Human Infection Models’
This report summarizes expert consensus reached during discussions regarding design and ethical considerations of Controlled Human...
Jan 24
Annual Meeting 2024 Inno4Vac: innovations to accelerate vaccine development and manufacture
October 2024 The 3rd Inno4Vac Annual Meeting and its’ Satellite Meetings took place at four locations over four days from 8-11 October...
Oct 16, 2024
Successful Regulatory Exchange on 3D Mucosal Models for Vaccine Development at RIVM
The third Inno4Vac Subtopic 3 (MERMAID) Regulatory stakeholder meeting- “A regulatory exchange on characterization and qualification of...
Jun 10, 2024
Inno4Vac interim review: advancing scientific and technological progress
On May 21-22 the Inno4Vac interim technical review successfully virtually took place.
Jun 4, 2024
Face to face VAXPRED meeting 31st May 2024
Representatives from all partner institutions met to discuss the progress of VAXPRED, the Subtopic 1 of Inno4Vac project
Jun 3, 2024
Four Key Reports highlighting regulatory and ethical aspects of the Controlled Human Infection Models
The Inno4Vac project aims to develop advanced and safe Controlled Human Infection Models (CHIMs) that can improve and accelerate vaccine...
Feb 22, 2024
New findings on vaccine efficacy prediction: comprehensive antibody repertoire profiling
January 2024 -Inno4Vac Subtopic 1 (VAXPRED), which is dedicated to building an open access and cloud-based platform to predict vaccine...
Jan 31, 2024
Regulatory engagement – continuing dialogue between ST4 model developers and EMA QIG
January 2024 Inno4Vac sub-topic 4 (VaXinS) aims to develop a hybrid model (a combination of a Compartmental Model [CM] and Kinetic...
Jan 16, 2024
Annual Meeting 2023 Inno4Vac: innovations to accelerate vaccine development and manufacture
October 2023 To advance the ambitious programme of Inno4Vac – which aims to harness the latest advances in immunology, disease modelling,...
Oct 18, 2023
Online platform on bio-manufacturing: workshop on integrating in silico models of unit operations
October 2023 Subtopic 4 ‘VAXinS’ of Inno4Vac is developing a modular one-stop computational platform for in silico modelling of vaccine...
Oct 16, 2023
Towards controlled human Clostridioides difficile colonization and infection
04 October 2023 The recent 13th International Conference on the Molecular Biology and Pathogenesis of Clostridia (CLOSTPATH), in Banff,...
Oct 4, 2023
1st Inno4Vac newsletter is out!
We are pleased to share the 1st Inno4Vac newsletter where you will find a summary of the communication efforts by EVI over the last few...
Sep 11, 2023
The Inno4Vac Scientific and Ethics Advisory Committee has been appointed
August 2023 Inno4Vac announces the nomination of the independent Scientific and Ethics Advisory Committee (SEAC) of the Inno4Vac project....
Aug 10, 2023
A regulatory exchange on diversity and standardisation of 3D mucosal models for vaccine development
The 2nd Inno4Vac ST3 (MERMAID) Regulatory stakeholder meeting was held June 27-28 and hosted by the Paul-Ehrlich-Institut in Langen, GE.
Jun 28, 2023
Subtopic 1 VAXPRED meeting on 8-9 May 2023
16 May 2023 The subtopic1, VAXPRED, dedicated to build an open access and cloud-based platform to predict vaccine efficacy using...
May 17, 2023
Annual Meeting 2022 Inno4Vac: innovations to accelerate vaccine development and manufacture
16 November 2022 To advance the ambitious programme of Inno4Vac, which aims to harness the latest advances in immunology and disease...
Nov 16, 2022
bottom of page